Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ViaLogy selected by Cisco

1 Apr 2008 13:00

ViaLogy PLC01 April 2008 ViaLogy Technology Integrated into New Cisco Open Platform for Safety and Security London, 1 April 2008: ViaLogy PLC (LSE: VIY), a leading innovator of real-timenetwork-centric signal processing platforms, announces its technology is beingintegrated into the Cisco Open Platform for Safety and Security (COPSS), the newCisco technology platform launched today at the annual FOSE 2008 industry tradeshow. The Cisco Open Platform for Safety and Security is a secure, intelligent,converged solution intended for multiple surveillance and alert applications tosupport the growing needs of defence, civilian, public safety, state and localgovernment agencies. It is to be offered by Cisco to public sector organizationson a worldwide basis. As a core member of the solution team, ViaLogy will provide the sensorintegration engine for the platform. ViaLogy's SPMTM (Sensor Policy Manager)software enables disparate sensors in very large enterprise networks to processand report only key events of interest to security personnel. The ViaLogytechnology is sensor agnostic and considerably enhances the performance andstrength of all integrated legacy and IP sensors, thus avoiding false alarms,missed events and optimizing use of limited bandwidth. ViaLogy's SPMTM is anintegral part of the Cisco Open Platform for Safety and Security demonstration -and available for viewing - at Cisco's Center of Excellence in Herndon,Virginia. "We are pleased to be working with Vialogy as part of our go-to-market team forthe Cisco Open Platform for Safety and Security," said Bruce Klein, Cisco'sfederal vice president. "Our strategy is to pull together an 'ecosystem' of theleading companies with expertise in protecting citizens, employees and criticalassets to provide the most comprehensive solution for facilitating collaborationfor government agencies. Vialogy delivers a critical piece of our overalltechnology platform." "Cisco has developed the Cisco Open Platform for Safety and Security to answer aworldwide requirement from customers for improved and co-ordinated integratedsafety and security systems," said Robert W. Dean. President and CEO of ViaLogy,"We are proud to be chosen as an approved supplier to the platform." "SPMTM is a comprehensive and flexible product that can be customised to suitindividual customer needs because we recognise that there are a variety ofsituations to be dealt with. Some customers will want a complete system forsecuring or monitoring a new building or area, others will want the overallintegration of existing and new security arrangements. "The Cisco Open Platform for Safety and Security will give common operationalpicture vigilance of all aspects of security, faster situation assessment,automated decision making and improved response time." ViaLogy has been closely involved in the development of an Improved DecisionSupport System for disparate sensors. As the Department of Defense drivesconvergence of physical security, consequence management and Chemical,Biological, Radiological/Nuclear, and Explosive (CBRNE) incidents to ensuresafety of military bases, scaleable network-centric technologies and IT productsare becoming increasingly important. ViaLogy has demonstrated its successes overthe past year during multiple Department of Defense demonstrations thatcontinually monitored and reported on CBRNE sensors in realistic scenarios.ViaLogy's SPMTM technology flawlessly linked all critical sensors to enableautomatic time alerts to the right person. This sensor integration andinteroperability capability will be a critical factor in next generationnetworked emergency alert systems. To find out more about the Cisco Open Platform for Safety and Security andViaLogy's participation please visit www.vialogy.com. ends Further information from: ViaLogy Robert W Dean, President/CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)Terry Bond, Chairman - UK & Europe +44 (0)1235 834734 Nominated Advisor (Seymour Pierce)Mark Percy +44 (0)20 7107 8000 PR Consultants - Redleaf CommunicationsSamantha Robbins / Anna Dunkin +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications and sensor fusion. ViaLogy is currentlydeploying and designing computational systems, powered by its patentedtechnologies, for applications in life sciences, public safety and security,surveillance, defence and geoseismology. Vialogy focuses on market drivenproblems where automation, timeliness, quality and reliability of informationprocessing are essential. ViaLogy's core competency incorporates rapidly andaccurately detecting weak signals buried in high noise background and clutter.This technology can be employed to solve problems involving sensor integrationand information overload challenges involving video, telephony and controlsensors, as well as for enhancement of numerous signal processing applications.For more information, visit our website at www.vialogy.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20203:00 pmRNSIssue of Share Options
25th Mar 20207:00 amRNSContract manufacturing agreement for COVID-19 test
16th Mar 20204:41 pmRNSSecond Price Monitoring Extn
16th Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 202011:51 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSAcquisition of French distribution channel
17th Feb 20207:00 amRNSCE Marking Technical File submission
14th Feb 202011:00 amRNSMedilink Award win for Outstanding Achievement
14th Feb 20207:00 amRNSTGA approves DPYD for sale in Australia
5th Dec 201912:10 pmRNSThe Healthcare+ Expo Taiwan
2nd Dec 20197:00 amRNSHalf-year Report
29th Nov 201912:05 pmRNSBionow Double Award Win
28th Nov 20197:00 amRNSOpening of New Facilities and Corporate HQ
15th Nov 20197:00 amRNSPrivate Investor Presentation
12th Nov 201910:12 amRNSNotice of Results
6th Nov 20191:52 pmRNSCapital Markets Day
1st Nov 20197:00 amRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSLaunch of Yourgene FlexT Analysis Software
30th Oct 20197:00 amRNSIssue of Share Options
15th Oct 20197:00 amRNSAmerican Society of Human Genetics Annual Meeting
14th Oct 20197:00 amRNSHalf year trading update
1st Oct 20197:00 amRNSPrivate Investor Presentation
26th Sep 20197:00 amRNSCE-IVD Certification renewal
18th Sep 20197:00 amRNSLaunch of DPYD chemotoxicity diagnostic assay
17th Sep 20195:50 pmRNSResult of AGM
17th Sep 20197:00 amRNSAGM Statement
20th Aug 20197:00 amRNSNotice of AGM
19th Aug 201910:35 amRNSChange of Registered Office
16th Aug 20193:49 pmRNSHolding(s) in Company
16th Aug 20199:06 amRNSDirectorate Change
12th Aug 20197:00 amRNSAmendment to Share Options
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
29th Jul 20197:00 amRNSAppointment of Director
10th Jul 20197:00 amRNSFinal Results, Business Update and Director Change
27th Jun 20197:00 amRNSNotice of Results
24th Jun 20197:00 amRNSYourgene participates in key global conferences
3rd Jun 20197:01 amRNSDirector's dealing
3rd Jun 20197:00 amRNSIssue of Share Options
9th May 20194:07 pmRNSDirector's dealing
9th May 20197:00 amRNSDirectors' dealing & warrant extension
1st May 20198:05 amRNSTotal Voting Rights
26th Apr 20195:12 pmRNSHolding(s) in Company
26th Apr 20195:01 pmRNSHolding(s) in Company
25th Apr 20194:40 pmRNSCompletion of Acquisition
18th Apr 20197:00 amRNSResults of Placing and Subscription
17th Apr 20194:50 pmRNSAppointment of Sole Corporate Broker
17th Apr 20194:48 pmRNSProposed Acquisition, Placing & Subscription
8th Apr 20197:00 amRNSFull-year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.